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Abstract
Background—While antismoking media campaigns have demonstrated effectiveness, less is 
known about the country-level effects of increased media dosing. The 2012 US Tips From Former 
Smokers (Tips) campaign generated approximately 1.6 million quit attempts overall; however, the 
specific dose–response from the campaign was only assessed by self-report.
Objective—Assess the impact of higher ad exposure during the 2013 Tips campaign on quit-
related behaviours and intentions, campaign awareness, communication about campaign, and 
disease knowledge.
Methods—A 3-month national media buy was supplemented within 67 (of 190) randomly 
selected local media markets. Higher-dose markets received media buys 3 times that of standard-
dose markets. We compared outcomes of interest using data collected via web-based surveys from 
nationally representative, address-based probability samples of 5733 cigarette smokers and 2843 
non-smokers.
Results—In higher-dose markets, 87.2% of smokers and 83.9% of non-smokers recalled 
television campaign exposure versus 75.0% of smokers and 73.9% of non-smokers in standard-
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dose markets. Among smokers overall, the relative quit attempt rate was 11% higher in higher-
dose markets (38.8% vs 34.9%; p<0.04). The higher-dose increase was larger in African-
Americans (50.9% vs 31.8%; p<0.01). Smokers in higher-dose markets without a mental health 
condition, with a chronic health condition, or with only some college education made quit attempts 
at a higher rate than those in standard-dose markets. Non-smokers in higher-dose markets were 
more likely to talk with family or friends about smoking dangers (43.1% vs 35.7%; p<0.01) and 
had greater knowledge of smoking-related diseases.
Conclusions—The US 2013 Tips antismoking media campaign compared standard and higher 
doses by randomisation of local media markets. Results demonstrate the effectiveness of a higher 
dose for engaging non-smokers and further increasing quit attempts among smokers, especially 
African-Americans.
INTRODUCTION
Globally, one tobacco-related death occurs approximately every 6 seconds, totalling about 
five million deaths annually.1 Deaths in the USA account for nearly 10% of the global death 
toll.2 The WHO recommends that all countries implement MPOWER,3 a multicomponent 
comprehensive approach to tobacco control. The ‘W’ in MPOWER stands for ‘Warn about 
the dangers of tobacco use’, referring to public education campaigns. However, public 
education campaigns require significant financial commitments. Although the effectiveness 
of tobacco campaigns has been established,4–13 important questions remain about how to 
optimise investment of scarce tobacco education campaign resources.
In 2012, the US Centers for Disease Control and Prevention (CDC) launched Tips From 
Former Smokers (Tips), the first federally funded, national tobacco education campaign in 
the USA. An estimated 1.6 million cigarette smokers made a quit attempt, and more than 
100 000 likely quit smoking permanently because of the 3-month campaign.8 The 2012 
campaign also was associated with increased intentions to quit smoking and changes in 
beliefs about smoking-related risks.14 Building on this success, CDC launched the second 
campaign in 2013. The 2013 Tips campaign aired for 16 weeks (4 March—21 June) and 
featured similar creative content as the 2012 campaign: graphic, emotional advertisements 
featuring people telling their true stories of suffering from smoking-related diseases, 
including chronic obstructive pulmonary disease (COPD), smoking-related diabetes 
complications and respiratory effects from secondhand smoke.815 The 2013 campaign aired 
nationally, with a significant national media buy on cable television (TV) and 
complementary ads in radio, print (figure 1), billboard, transit and digital outlets. All video, 
radio and print ads can be found at http://www.cdc.gov/tips.15
The 2012 Tips campaign had a ubiquitous national buy and a local buy-up strategy that 
focused on high-prevalence localities; consequently, a randomised field trial with a non-
exposed group to assess the effect of increased media exposure was not possible. Very few 
studies have been conducted that control the intensity of media buys with the intention of 
evaluating the impact of dose on outcomes.1617 For example, from 2000 to 2002, several 
matched pairs of US communities were randomised to either increased or standard doses of 
the national ‘truth’ campaign.16 A similar matched-pair design with random assignment to 
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increased or standard media doses was conducted in 2007 among several rural communities 
as part of Legacy’s ‘truth or consequences’ campaign evaluation.17 Both these studies 
generated modest to moderate contrasts in community-level exposure. However, they did not 
demonstrate, based on randomisation status, that these exposure contrasts were sufficient to 
influence changes in tobacco-related behavioural outcomes. Because even small changes in 
quit attempt rates are important at the population level, large samples are also necessary to 
detect effects.
As demonstrated by these studies, field-based designs with controlled media are difficult and 
expensive to implement, and they may not yield sufficient exposure contrast without 
prohibitively large evaluation sample sizes. For example, the ‘truth’ campaign study16 using 
matched pairs of communities with random media dosing assignments ultimately relied on 
self-reported ad exposure, without regard to randomisation category to detect outcome 
differences. Consequently, as part of the 2013 Tips evaluation, we sought to determine the 
impact of increasing the dose of ad exposure on smokers and non-smokers, given previous 
evidence of standard-dose effectiveness.8 Furthermore, we wanted to determine the effect of 
a higher dose in priority subpopulations, including African-Americans, Hispanics, those 
with chronic mental and physical diseases, and those not completing college. Therefore, in 
addition to a standard-dose national media buy, 2013 Tips increased ad exposure in 
randomly selected local markets to assess the dose–response impact on campaign awareness, 
quit-related behaviours and intentions, communication about the campaign, and disease 
knowledge among smokers and non-smokers.
METHODS
Study design
The 2013 Tips campaign built on the research and approach used in the development of the 
2012 Tips campaign ads. Real people (not actors) with smoking-related health conditions 
were featured in five new 30 second TV ads focusing on the impact of smoking on quality of 
life. The new ads were aired along with six ads from 2012, from 4 March 2013 to 17 June 
2013. In addition, there was a much smaller ad component consisting of radio, billboards 
and print media featuring some of the same ad participants, as well as a website featuring 
ads, ad participants and cessation support materials. Doses of these media channels were not 
manipulated in the experiment (only TV dose was increased).
The 2013 campaign aimed to air an average of 800 TV gross rating points (GRPs) to all US 
markets. GRPs are a standard measure of advertising intensity calculated at the market level 
by Nielsen Media Research based on TV viewership estimates. Ad GRPs are defined as the 
product of the percentage of the population potentially exposed to advertising (reach) and 
the average number of times the ads were seen (frequency). GRPs have been used in 
multiple evaluations of tobacco counter-advertising campaigns.5101218 To examine the dose–
response impact of the campaign, we aimed to air an additional 1600 TV GRPs in randomly 
selected local markets, representing an extra dose that was double that of the 2013 Tips 
national media buy, for a total of approximately 2400 GRPs.
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The 20 largest US markets were excluded from randomisation eligibility because of the 
prohibitive expense of purchasing additional advertising in these markets. The remaining 
190 markets were stratified by key characteristics associated with cigarette smoking 
prevalence (age, race/ethnicity, gender and education) and randomised within each stratum. 
Based on available funding for local media buys, the probability of random assignment to a 
higher dose within each stratum was 35%. These parameters yielded 67 markets in the 
higher-dose group and 123 markets in the standard-dose group (figure 2).
To confirm similarity between the two randomised groups, we compared 2010 US Census 
demographic characteristics between the standard-dose and higher-dose markets. We also 
examined market-level cigarette smoking prevalence—aggregated across market counties 
and weighted by population—using 2012 Behavioral Risk Factor Surveillance System 
county-level smoking prevalence data.19 Finally, we examined differences in state-level 
tobacco control practices between the two randomised groups using recent state-level 
cigarette tax data20 and state per capita tobacco control expenditures.21
Survey data and sample
We analysed nationally representative survey data from smokers and non-smokers, 
respectively, collected shortly after the end of the 2013 Tips campaign (8 July 2013 to 1 
October 2013). The sample was recruited from GfK’s online KnowledgePanel (KP)82223 and 
included all previously available and newly recruited smokers, as well as a random selection 
of non-smokers. KP participants are recruited using address-based probability sampling, 
covering over 95% of US households. Because of the smaller number of higher-dose 
markets, panellists were oversampled from higher-dose markets to increase power. Panellists 
cannot volunteer for panel enrolment, and all participants have known probabilities of 
selection. Smokers were defined as adults aged 18 years or older who had smoked at least 
100 cigarettes in their lifetime and reported currently smoking either every day or some days 
at the time of the 2013 Tips campaign launch. Non-smokers were adults aged 18 years or 
older who never smoked or did not smoke at the time of the survey. Current non-smokers 
who reported quitting since the launch of the campaign were considered to be smokers at the 
time of campaign launch and were counted as having made a quit attempt in the main 
smoker quit attempt analysis.
Survey weights were calculated to yield estimates representative of the markets in each 
randomised condition. A weighting procedure24 was performed to constrain each of the 
standard-dose and higher-dose samples to a common distribution of age, gender, race/
ethnicity and education matching the US Census distributions of these variables in the 
combined set of higher-dose and standard-dose markets.
For smokers, the final analytic sample consisted of 3208 respondents in higher-dose markets 
and 2525 respondents in standard-dose markets. For non-smokers, the final analytic sample 
consisted of 1367 respondents in higher-dose markets and 1476 respondents in standard-
dose markets. The overall survey completion rate was 56% among KP participants screened 
for survey participation. Power analysis was conducted based on anticipated effects of the 
higher-dose buy on quit attempts. Accounting for sample sizes in each randomised group, 
anticipated effect size of 4.4% based on limited data from a state campaign,7 market-level 
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clustering and variability in market sample sizes, the sample was estimated to have 85% 
power to detect this size effect on the probability of a quit attempt.
Measures
Among smokers, the primary outcome was the incidence of making at least one quit attempt 
lasting 1 day or longer since the 2013 Tips campaign launch. Intentions to quit smoking 
(within 30 days and 6 months) were also measured as outcomes. Among non-smokers, key 
outcome measures were communication with friends or family about the dangers of smoking 
and encouragement to quit and use cessation resources. Among smokers and non-smokers, 
we also measured campaign awareness and exposure frequency. Dichotomous indicators 
assessed knowledge that health conditions highlighted in the 2013 Tips campaign—
including tracheotomy, COPD, Buerger’s disease, amputations, heart disease, stroke, 
diabetes complications and asthma—were related to smoking, as well as a non-related 
dummy condition (gallstones) and some smoking-related diseases not highlighted in 2013 
ads.
Self-reported exposure to campaign advertisements was measured using a standard ad 
recognition protocol.25 Respondents viewed seven TV ads to prompt recall. All respondents 
viewed the six ads that were run most frequently, and a seventh ad chosen at random from 
the remaining five less-frequently shown ads. Immediately after viewing each ad, 
respondents were asked ‘Have you seen this ad on television in the past (# months) months 
since 4 March 2013?’ Respondents could answer yes or no to this question. Respondents 
who answered yes to the ad recall question were then asked, ‘In the past (# months since 4 
March 2013) months, how frequently have you seen this ad on television?’ Response options 
included rarely, sometimes, often or very often. This process was repeated for each ad, with 
the ad display order randomised. Respondents unable to view ads via the within-survey 
video stream saw a screenshot storyboard and an ad script.
Overall campaign awareness was calculated as the percentage of the sample that indicated 
they had seen at least one 2013 Tips ad since the campaign launch. A frequency of exposure 
index was created to measure respondents’ total exposure to these TV ads. This measure is 
defined as the sum of the mean recall frequencies (0=never saw ad, 4=saw ad very often) 
across all 2013 Tips TV ads shown to the respondent.
Demographic covariates measured in the survey included age, gender, race/ethnicity, 
education, annual household income, TV hours per day, household presence of children aged 
17 years or younger, household presence of a cigarette smoker, and having a chronic and/or 
mental health condition. In addition, external state-level and market-level variables were 
merged to the survey data, including cumulative state per capita tobacco control programme 
funding (1985–2012); state cigarette excise tax (2012); and market-level population size, 
median income (in tens of thousands of dollars) and the percentage of the population with a 
bachelor’s degree. We also measured market-level cigarette smoking prevalence by 
aggregating recently published county-level data on smoking prevalence19 to the market 
level, weighted by county population.
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The impact of the higher dose was first assessed with weighted bivariate comparisons of key 
outcomes in the randomised higher-dose and standard-dose markets, with one-tailed 
statistical tests for between-market differences. We used one-tailed tests as our principal test 
of significance because our study was a real-world, pragmatic dosing test where all past 
research on cessation-focused campaigns, including the 2012 Tips evaluation,8 strongly 
suggested that increased dosing from a low baseline delivered over a relatively short time 
would either increase effects or have no effect.57111226–28 We then used multivariate analysis 
to estimate each outcome as a function of the higher-dose condition. We included in our 
multivariate models covariates for any individual, market or state-level characteristics that 
differed statistically between randomised dosing conditions. We also conducted additional 
stratified analyses among smokers to assess campaign effects by age, education, race/
ethnicity, and presence of a chronic and/or mental health condition. The survey ‘logistic’ and 
‘regress’ commands in Stata29 were used for model estimation, and estimated logistic 
coefficients were converted to odds ratios (ORs) to facilitate model interpretation.
RESULTS
Randomisation and sample characteristics
The national media buy was almost identical between the standard-dose and higher-dose 
markets (761 vs 758 GRPs). The higher-dose markets received an additional 1724 GRPs. 
Age, gender, race/ethnicity and education distributions were identical between the standard-
dose and higher dose markets after applying the weighting procedures. There was a small 
but statistically significant difference in market-level smoking prevalence between the 
higher-dose (23.0%) and standard-dose markets (22.1%). Mean state cigarette taxes, 
cumulative per capita state tobacco control programme expenditures and college completion 
were not significantly different between groups. There was a small but statistically 
significant difference in median income (US$41.1 K higher-dose market; US$42.5 K 
standard-dose market) and population size (944 K higher-dose market; 969 K standard-dose 
market).
Among smokers in the weighted survey sample (table 1), there were small but statistically 
significant differences in household income and presence of a mental health condition. The 
only significant difference by randomised higher-dose condition in the weighted non-smoker 
sample was presence of another smoker in the household. Covariates for these characteristics 
were included in our multivariate models of the associations between the higher-dose 
condition and each outcome variable for smokers and non-smokers.
Ad exposure
Among all respondents, 86.2% viewed the ads via in-survey video streaming; the remaining 
respondents referenced screen-shots. Of the respondents viewing ads, 82.2% watched each 
ad for at least 20 seconds. Among smokers, 87.2% in higher-dose markets reported seeing at 
least one Tips ad compared with 75.0% in standard-dose markets (p<0.01)—an absolute 
difference of 12.2% (adjusted odds ratio (aOR)=2.16; p<0.01), which represents a relative 
increase of 16.3% (table 2). The frequency of ad exposure index was higher among smokers 
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in higher-dose markets than standard-dose markets (8.04 vs 5.09), a relative increase of 
58.0% (β=2.85, p<0.01; table 2). Average frequency of exposure overall was 8.06 for 
African-Americans versus 5.95 for Caucasians (p<0.01). Frequency of exposure increased in 
higher-dose market from 6.86 to 10.56 among African-Americans (p<0.01) versus 4.99 to 
7.95 among Caucasians (p<0.01).
Impact on outcomes among all smokers
Among smokers, the incidence of making a quit attempt was higher in higher-dose markets 
(38.8%) than in standard-dose markets (34.9%)—an absolute difference of 3.9%, which 
represents a relative increase of 11.2% (aOR=1.20; p<0.03; table 2). Knowledge that 
amputations can result from smoking was higher (p<0.01) in higher-dose markets (50.2%) 
than in standard-dose markets (43.5%; aOR=1.31; p<0.01), as was knowledge that smoking 
can worsen diabetic complications (88.5% vs 84.2%; aOR=1.43; p<0.05) and knowledge of 
smoking-related COPD or chronic bronchitis (91.8% vs 88.9%; aOR=1.35; p<0.05). 
Intentions to quit smoking in the next 30 days or 6 months were not significantly different 
between higher-dose markets and standard-dose markets or for any of the remaining disease 
knowledge outcomes, although intention to quit in 6 months approached significance in the 
multivariate model (p=0.06; table 2).
Impact on ad exposure and outcomes among non-smokers
Among non-smokers, 83.9% of respondents in higher-dose markets reported seeing at least 
one Tips ad compared with 73.9% in standard-dose markets (p<0.01)—an absolute 
difference of 10.0% (aOR=1.79; p<0.01), which represents a relative increase of 13.5% 
(table 3). Frequency of exposure among non-smokers was 63.2% higher in higher-dose 
markets compared with standard-dose markets (7.28 vs 4.46, p<0.01; β=2.61, p<0.01).
Talking with friends or family about the dangers of smoking was more frequent among non-
smokers (p<0.01) in higher-dose markets (43.1%) than in standard-dose markets (35.7%; 
aOR=1.26, p=0.03; table 3). Similarly, encouraging others who smoke to quit was higher 
(p=0.03) among non-smokers in higher-dose markets (45.5%) than in standard-dose markets 
(40.0%), but this difference was not significant in multivariate analysis (aOR=1.14, p=0.14). 
Knowledge of smoking-related diseases was significantly greater in higher-dose markets 
than in standard-dose markets for lung cancer (aOR=2.64), cancer of the mouth or throat 
(aOR=2.65), heart disease (aOR=1.65), emphysema (aOR=1.65), hole in throat (stoma or 
tracheotomy; aOR=2.19), amputations (aOR=1.67), asthma (aOR=1.59), COPD (or chronic 
bronchitis; aOR=2.48), and worsening of diabetic complications (aOR=1.70) in bivariate 
and multivariate analysis (all p<0.05). Knowledge of stroke as a smoking-related disease 
was significantly higher in bivariate analysis (p<0.01), and at the significance margin in 
multivariate analysis (aOR=1.34, p=0.05).
Impact on quit attempts among smokers by demographic subgroup
The increase in quit attempt incidence in higher-dose markets compared with standard-dose 
markets was greater for some demographic subgroups (table 4). African-American smokers 
reported markedly higher quit attempt incidence in higher-dose markets (50.9%) compared 
with standard-dose markets (31.8%; aOR=1.96; p<0.01). Quit attempt rates were higher 
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(p<0.05) among Hispanic smokers (56.3%) in higher-dose markets than in standard-dose 
markets (39.9%); however, this difference was not significant in multivariate analysis 
(aOR=1.30; p=0.27). There was no statistically significant difference (p=0.23) in the quit 
attempt rate among Caucasians between higher-dose (33.4%) and standard-dose (34.8%) 
markets. Smokers with only some college education reported higher quit attempt incidence 
in higher-dose markets (45.4%) compared with standard-dose markets (33.9%; aOR=1.60; 
p<0.01). However, there was no significant effect in smokers who completed college. 
Respondents with chronic diseases (non-mental) reported higher quit attempt rates in higher-
dose markets (39.3%) compared with standard-dose markets (32.0%; aOR=1.21; p<0.03). 
Respondents without a mental health condition reported higher quit attempt rates in higher-
dose markets than standard-dose markets (38.5% vs 32.0%; p<0.01), whereas respondents 
with a mental health condition did not (39.5% vs 42.5%; p=0.79). However, among 
respondents in standard-dose markets, the quit attempt rate was higher among those 
reporting a mental health condition than among those not reporting a mental health condition 
(42.5% vs 32.0%; p<0.01).
DISCUSSION
Higher-dose local ad buys in randomly selected markets in the 2013 Tips study generated a 
3.9% absolute increase (11.2% relative increase) in quit attempts above the base rate in 
standard-dose markets (34.9% vs 38.8%). Consistent with the results of a 2012 longitudinal 
cohort trial, these findings from a randomisation of markets in 2013 indicate the 
effectiveness of media campaigns for rapidly increasing quit attempts among smokers and 
engaging non-smokers. The 2012 Tips evaluation used a pre-post analysis that determined 
the campaign generated a 3.7% absolute increase in quit attempts nationally from 31.1% to 
34.8%, resulting in 1.6 million quit attempts.8
The 2013 higher-dose ad buy had a more substantial impact on African-Americans, who had 
a 50.9% quit attempt rate in higher-dose markets compared with 31.8% in standard-dose 
markets (60.1% relative increase). This dramatic relative increase may be related to 
increased ad exposure and receptivity, as documented in previous studies examining 
African-American antismoking ad response. For example, some prior studies have shown 
that African-Americans are more likely to rate antismoking ads high on measures of 
‘perceived ad effectiveness’, which is predictive of smoking-related outcomes.3031 
Additionally, bivariate analysis revealed substantial increases in quit attempts among 
Hispanics (56.3% vs 39.9%), although this increase was not statistically significant by 
multivariate analysis. This lack of significance despite a 1.3 OR could be related to 
insufficient power to detect a subpopulation effect. We also observed an increased impact 
among those completing only some college without graduating, which represents almost a 
third of US adults.32 Those with chronic physical conditions benefitted from the higher-dose 
buy, which may reflect pre-existing increased motivation because of the effects of smoking. 
The standard-dose quit attempt rate was higher in those with mental health conditions than 
those without; however, no additional dose effect was observed. This is consistent with other 
recent evidence suggesting that smokers with mental illness are more likely to make quit 
attempts than those without mental illness, although their success rate is lower.33
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Among smokers and non-smokers, knowledge of smoking-related disease conditions was 
generally greater in higher-dose markets. This impact was stronger for the disease conditions 
explicitly highlighted in the 2013 Tips campaign. No significant impact was observed for 
conditions unrelated to the 2013 Tips ads, with the exception of lung cancer and oral cancer 
in non-smokers (emphysema, which is a form of COPD, was significant in multivariate but 
not bivariate analysis). The lung cancer and oral cancer exceptions may have been because 
of a tracheostomy ad and a lung surgery ad (for COPD) that viewers interpreted as related to 
oral and lung cancer. In general, our results demonstrate that the campaign affected targeted 
outcomes and not unrelated ones. For example, knowledge that smoking worsens diabetic 
complications was higher with the higher dose, whereas knowledge that smoking causes 
diabetes was not. This is consistent with the focus of the 2013 diabetes ad, which focused on 
worsening complications in a person with existing diabetes.
Among non-smokers, talking with friends or family about the dangers of smoking was 
significantly more frequent in higher-dose markets. Increases in campaign-related disease 
knowledge among non-smokers were even more consistently associated with campaign ads 
than among smokers. These findings may be of particular interest in countries where fewer 
tobacco control policies are in place, public awareness of the dangers of smoking is low or 
the baseline quit attempt rate is low. In this circumstance, higher-dose media campaigns 
might increase non-smoker support for policy change and increase friends or family talking 
about the dangers of smoking. However, further country-specific consideration and 
evaluation of the relative costs and benefits is warranted.
The additional dose to create the overall incremental effects in 2013 was significantly larger 
(approximately 1700 GRPs) than the national dose delivered in 2012 (1000 GRPs). 
Consequently, the 2012 Tips campaign required about 270 GRPs per percentage point 
increase in overall quit attempts, whereas 2013 Tips higher dose required over 400 
additional GRPs per percentage point increase. This comparison is based on the presumptive 
equivalence in execution between the 2012 and 2013 campaigns, because each campaign 
used similar message styles, themes and even some of the same ad participants. However, a 
higher-dose strategy may be efficient for subgroups where larger effects were seen, most 
notably for African-American smokers, who had a 19.1% absolute increase. Because higher-
dose local buys are often more expensive, purchasing more national coverage, including via 
African-American national media channels, may be more cost-effective. A return-on-
investment study is in progress to examine this and other questions.
Randomisation of a mass media intervention at the level of delivery in a majority of US 
markets is a strength of this study because randomisation decreases the likelihood of 
confounding or reverse causation accounting for detected effects. Measurement of quit 
attempts (an important public health outcome), large sample size, multivariate analysis to 
account for variation between randomised markets, examination of effects on non-smokers 
and key subpopulations of smokers, and use of address-based nationally representative 
samples are also strengths.
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Our study has several limitations. Although we used a probability sample designed to be 
representative of the higher-dose market and standard-dose market populations, the surveys 
were conducted online, and respondents who joined the study may have been different from 
those who declined. In addition, Tips campaigns have been relatively short (3–4 months) 
compared with other regional and country-level campaigns. Also, although having survey 
follow-up occur immediately after the campaign may be a strength for detecting immediate 
effects, we were unable to measure delayed effects on quit attempts and long-term 
abstinence beyond the follow-up window. In addition, we did not have sufficient 
demographic information or statistical power to explore differential effects on other key 
subpopulations, such as sexual and gender minorities and other racial/ethnic groups. Further, 
any lack of positive findings for subpopulations we did examine should be interpreted with 
caution because sample size varied considerably. For example, the lack of effect for 
Hispanics with multivariate analysis despite a large absolute and relative percentage increase 
may be due to a lack of statistical power.
Application and interpretation of our results may be influenced by how media markets 
function, how we measured recall and the baseline dose in the standard condition. Regional 
versus national buy efficiency may depend on local specifics of how media markets are 
segmented and purchased and how subpopulations react to media campaigns. We measured 
recall of any ad based on showing each respondent 7 of 11 ads that were played during the 
campaign. Consequently, our reported recall fraction may be lower than would have been the 
case if we had shown respondents all 11 ads. In addition, a lack of positive findings for 
comparisons made in this study is only relevant to the question of incremental impact of a 
higher dose above baseline. Because all respondents received a baseline dose, a lack of 
positive findings from the higher dose should not be interpreted to mean that baseline media 
does not produce an effect.
Because the 20 largest US markets were excluded due to prohibitive costs, our findings 
reflect the impact of additional media on small-sized to medium-sized markets. Furthermore, 
the tobacco control policy environment in the 20 largest markets is generally more 
favourable than that of the study markets (eg, 85.9% clean indoor air law vs 68.2%; state 
excise tax $1.61 vs $1.29). Prior evaluation of mass media campaigns suggests they produce 
larger effects when conducted in markets with complementary tobacco control policies.10 
Consequently, our findings may underestimate the effect size of a higher dose at the national 
level that would include large markets. Finally, we were unable to adjust for heavier 
smoking because this was a postintervention-only survey, and we cannot accurately establish 
the respondents’ dependence status prior to the campaign without assuming that dependence 
level did not change during the campaign time period.
CONCLUSIONS
Future research and economic modelling34 may be useful to further hone the application of 
these findings to future campaigns. Because we focused solely on cigarettes, evaluation of 
future campaigns that include other tobacco products may be useful. Campaign developers 
and evaluators may benefit from examining differential campaign effects on key 
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subpopulations. Development and evaluation of future ads may benefit from additional 
exploration of the impact of ads on groups responding less strongly, such as those with no 
college education, Caucasians and those with a mental health condition.
In 2014, the US Surgeon General released the 50th anniversary report on the health 
consequences of smoking. Although 8 million lives had been saved by tobacco control 
nationally, 5.6 million US children alive today will die prematurely from smoking if more 
dramatic action is not taken. One billion people worldwide will die in the 21st century unless 
trends are reversed. One of the report’s key recommendations was to counteract “industry 
marketing by sustaining high impact national media campaigns like the CDC’s Tips From 
Former Smokers campaign and FDA’s youth prevention campaigns at a high frequency level 
and exposure for 12 months a year for a decade or more (p. 875).”2 We now have conducted 
two rigorous country-level real-world trials: a longitudinal pre-post cohort study in 20128 
and a randomised field trial of market-level dosing in 2013. Both studies demonstrate the 
effectiveness of carefully designed and delivered media campaigns for engaging non-
smokers and rapidly increasing quit attempts among smokers, especially African-Americans, 
those with only some college education, and those with a non-mental health chronic disease. 
Our findings add a new level of empirical support to previous studies conducted in low-
income and middle-income countries35 and consequently support WHO’s MPOWER 
recommendation to all countries for investment in tobacco education.3
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What this paper adds
• Tobacco control strategies, including public education campaigns, have 
been shown to be effective in promoting behavioural changes, 
including incidence of quit attempts.
• The 2012 US Tips From Former Smokers national tobacco education 
campaign generated an estimated 1.6 million population-level quit 
attempts.
• Evaluation of the impact of higher doses of tobacco prevention media 
campaigns has generally been limited to state-based or regional 
campaigns using non-randomised designs.
• Little is known about the effects of media dosing above Centers for 
Disease Control and Prevention (CDC)-recommended minimum 
advertising levels on cessation behaviour.
• Examination of campaign effects on key subpopulations—such as 
lower education, racial/ethnic minorities, and those with chronic 
physical and mental health conditions—has been lacking.
• Our findings demonstrate the effectiveness of higher doses of media on 
rapidly increasing quit attempts among smokers, especially among 
African-Americans.
• Non-smokers report increased conversations with family or friends 
about the dangers of smoking and have greater knowledge of smoking-
related diseases at a higher media dose.
• This is the first study to demonstrate the effectiveness of a national 
tobacco education campaign using field-based randomisation at the 
media market level.
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Print advertisement from the 2013 Tips campaign. CDC, Centers for Disease Control and 
Prevention; Tips, Tips From Former Smokers.
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Flow diagram: randomised media dosing, 2013 Tips evaluation. GRP, gross rating point; 
Tips, Tips From Former Smokers.
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